Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)
LXRX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-47.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
23%
LXRX Stock Analysis
LXRX
PE Ratio:
LXRX
PEG Ratio:
Not Available
LXRX
Forward EPS Growth (12 month):
0.00%
LXRX
PS Ratio:
11.8
LXRX
PSG Ratio:
-0.3
LXRX
Forward Revenue Growth (12 month):
-42.30%
LXRX Articles
No data was found